We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) EMGALITY galcanezumab 120mg/mL solution for injection in pre-filled pen (Germany)
Section 19A approved medicine
(Approval lapsed) EMGALITY galcanezumab 120mg/mL solution for injection in pre-filled pen (Germany)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
EMGALITY galcanezumab 120mg/mL prefilled pen - ARTG 302146
Indication(s)
EMGALITY is indicated for the prophylaxis of migraine in adults.
Images
